Xspray Pharma AB (publ) (STO:XSPRAY)

Xspray Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,094	1,539	1,250	1,293	1,326	3,665
Market Cap Growth	23.14%	23.14%	-3.30%	-2.48%	-63.83%	162.97%
Enterprise Value	1,014	1,498	1,118	1,205	1,113	3,554
Last Close Price	29.45	41.45	39.53	56.32	63.34	191.70
PB Ratio	1.76	2.47	1.80	2.33	2.24	6.29
P/TBV Ratio	2.47	2.47	1.80	2.33	2.24	6.29
Debt / Equity Ratio	0.21	0.21	0.05	0.00	0.01	0.01
Quick Ratio	1.45	1.45	4.27	4.26	9.16	16.60
Current Ratio	1.61	1.61	5.46	4.58	9.41	16.70
Return on Equity (ROE)	-43.38%	-43.38%	-28.76%	-22.94%	-16.47%	-10.96%
Return on Assets (ROA)	-22.50%	-22.50%	-16.73%	-13.59%	-9.87%	-6.67%
Return on Capital (ROIC)	-23.72%	-23.72%	-17.54%	-14.24%	-10.25%	-6.94%
Earnings Yield	-26.11%	-18.55%	-14.37%	-10.18%	-7.29%	-1.43%
FCF Yield	-20.73%	-14.73%	-16.48%	-10.42%	-3.99%	-1.43%
Buyback Yield / Dilution	-24.61%	-24.61%	-26.21%	-9.53%	-11.77%	-13.11%

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.